Becton, Dickinson and Co.

XNYSHealth care

Last traded price · USD

$206.50

−1.29%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $209.19
Volume: 144
Day's high: —
Day's low: —

In brief

Becton, Dickinson and Co. is a health care company listed on the New York Stock Exchange, valued at about $56.25B.
Its shares closed at $209.19 on 4 Nov 2026, up 16.8% over the past year.
From India you can buy BDX in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Becton, Dickinson and Co. (BDX) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole BDX share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade BDX options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

1.8% below its 52-week high
Closed at $209.19 on 4 Nov 2026: 1.8% below the 52-week high of $213.08 (4 Feb 2026) and 49.3% above the low of $140.11 (22 Jun 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Ahead of SPY, behind its sector fund XLV over 1 year
1 month: +16.0% (SPY −1.6%, XLV +13.5%). 3 months: +22.6% (SPY −0.4%, XLV +15.5%). 1 year: +16.8% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: BDX, SPY and XLV · as of 4 Nov 2026
Rose 5.6% on 4 Nov 2026
The 4 Nov 2026 gain of 5.6% was 4.3× its average daily move of 1.3% over the past year, and its largest one-day gain since 7 May 2026.
Daily closes, split-adjusted · as of 4 Nov 2026
5.5 days to cover short interest
8.9M shares were sold short at the 15 Oct 2026 settlement, 3.2% of the 275.5M shares outstanding; covering them would take 5.5 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Volume 2.8× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 4.5M shares was 2.8× the average of the 30 sessions before it (1.6M), as the price rose 5.6%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+16.0%

6 months+44.5%

1 year+16.8%

5 years−14.3%

Newswire

About

Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.

Website

Notable moves

February 10, 2026
−17.22%
May 1, 2025
−18.13%
November 9, 2023
−9.25%

Becton, Dickinson and Co.

XNYSHealth care

Last traded price · USD

$206.50

−1.29%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $209.19
Volume: 144
Day's high: —
Day's low: —

In brief

Becton, Dickinson and Co. is a health care company listed on the New York Stock Exchange, valued at about $56.25B.
Its shares closed at $209.19 on 4 Nov 2026, up 16.8% over the past year.
From India you can buy BDX in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Becton, Dickinson and Co. (BDX) shares from India?

Do I need the price of a whole BDX share to invest?

How much can I invest in US stocks in a year?

Can I trade BDX options or futures?

Insights

Quotes run fifteen minutes behind.

1.8% below its 52-week high
Closed at $209.19 on 4 Nov 2026: 1.8% below the 52-week high of $213.08 (4 Feb 2026) and 49.3% above the low of $140.11 (22 Jun 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Ahead of SPY, behind its sector fund XLV over 1 year
1 month: +16.0% (SPY −1.6%, XLV +13.5%). 3 months: +22.6% (SPY −0.4%, XLV +15.5%). 1 year: +16.8% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: BDX, SPY and XLV · as of 4 Nov 2026
Rose 5.6% on 4 Nov 2026
The 4 Nov 2026 gain of 5.6% was 4.3× its average daily move of 1.3% over the past year, and its largest one-day gain since 7 May 2026.
Daily closes, split-adjusted · as of 4 Nov 2026
5.5 days to cover short interest
8.9M shares were sold short at the 15 Oct 2026 settlement, 3.2% of the 275.5M shares outstanding; covering them would take 5.5 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Volume 2.8× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 4.5M shares was 2.8× the average of the 30 sessions before it (1.6M), as the price rose 5.6%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+16.0%

6 months+44.5%

1 year+16.8%

5 years−14.3%

Newswire

About

Website

Notable moves

February 10, 2026
−17.22%
May 1, 2025
−18.13%
November 9, 2023
−9.25%

Becton, Dickinson and Co.

Becton, Dickinson and Co. in brief

1.8% below its 52-week high

Ahead of SPY, behind its sector fund XLV over 1 year

Rose 5.6% on 4 Nov 2026

5.5 days to cover short interest

Volume 2.8× its 30-session average on 4 Nov 2026

Becton, Dickinson and Co.

Becton, Dickinson and Co. in brief

1.8% below its 52-week high

Ahead of SPY, behind its sector fund XLV over 1 year

Rose 5.6% on 4 Nov 2026

5.5 days to cover short interest

Volume 2.8× its 30-session average on 4 Nov 2026